Kirsch B, DuBois J, Chadha D. A Multi-Center, Open-Label Study to Assess Pharmacokinetics (PK), Safety and Tolerability of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, ≥9 to <17 Years of Age, with Axillary Hyperhidrosis. J of Skin [Internet]. 2019Nov.9 [cited 2024Sep.20];3:S54. Available from: https://dermsquared.com/skin/article/view/782